Oruka Therapeutics (ORKA) EBIT (QoQ) (2010 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -25.79% |
| Mar 31, 2024 | -56.10% |
| Dec 31, 2023 | 17.91% |
| Sep 30, 2023 | 1.82% |
| Jun 30, 2023 | -9.86% |
| Mar 31, 2023 | -16.02% |
| Dec 31, 2022 | 39.34% |
| Sep 30, 2022 | 20.72% |
| Jun 30, 2022 | 1.77% |
| Mar 31, 2022 | 42.31% |
| Dec 31, 2021 | -20.44% |
| Sep 30, 2021 | 2.50% |
| Jun 30, 2021 | -17.92% |
| Mar 31, 2021 | 19.98% |
| Dec 31, 2020 | -157.59% |
| Sep 30, 2020 | -51.91% |
| Jun 30, 2020 | 2.24% |
| Mar 31, 2020 | -4.85% |
| Dec 31, 2019 | -2.49% |
| Sep 30, 2019 | 17.31% |
| Jun 30, 2019 | 15.33% |
| Mar 31, 2019 | -136.16% |
| Dec 31, 2018 | 396.33% |
| Sep 30, 2018 | 22.91% |
| Jun 30, 2018 | 22.25% |
| Mar 31, 2018 | -134.11% |
| Dec 31, 2017 | 281.65% |
| Sep 30, 2017 | 19.50% |
| Jun 30, 2017 | -26.89% |
| Mar 31, 2017 | -2.07% |
| Dec 31, 2016 | 8.91% |
| Sep 30, 2016 | -19.56% |
| Jun 30, 2016 | -7.44% |
| Mar 31, 2016 | -15.53% |
| Dec 31, 2015 | -12.71% |
| Sep 30, 2015 | -3.60% |
| Jun 30, 2015 | 0.91% |
| Mar 31, 2015 | -5.05% |
| Dec 31, 2014 | -14.31% |
| Sep 30, 2014 | 5.03% |
| Jun 30, 2014 | -0.67% |
| Mar 31, 2014 | 18.90% |
| Dec 31, 2013 | -70.84% |
| Sep 30, 2013 | -43.99% |
| Jun 30, 2013 | -11.96% |
| Mar 31, 2013 | -154.37% |
| Dec 31, 2012 | 312.07% |
| Sep 30, 2012 | 18.95% |
| Jun 30, 2012 | 18.56% |
| Mar 31, 2012 | 13.95% |
| Dec 31, 2011 | 10.27% |
| Sep 30, 2011 | -6.87% |
| Jun 30, 2011 | 22.62% |
| Mar 31, 2011 | 6.38% |
| Dec 31, 2010 | -11.68% |
| Sep 30, 2010 | 7.18% |